O
Ossiam’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-268
| Closed | -$40.3K | – | 644 |
|
2025
Q1 | $40.3K | Sell |
268
-533
| -67% | -$80.2K | ﹤0.01% | 580 |
|
2024
Q4 | $148K | Sell |
801
-75
| -9% | -$13.8K | ﹤0.01% | 542 |
|
2024
Q3 | $173K | Buy |
876
+837
| +2,146% | +$165K | ﹤0.01% | 550 |
|
2024
Q2 | $8.06K | Buy |
39
+30
| +333% | +$6.2K | ﹤0.01% | 622 |
|
2024
Q1 | $2.44K | Sell |
9
-664
| -99% | -$180K | ﹤0.01% | 626 |
|
2023
Q4 | $159K | Buy |
673
+9
| +1% | +$2.13K | ﹤0.01% | 603 |
|
2023
Q3 | $130K | Sell |
664
-24
| -3% | -$4.7K | ﹤0.01% | 622 |
|
2023
Q2 | $145K | Buy |
688
+278
| +68% | +$58.5K | ﹤0.01% | 632 |
|
2023
Q1 | $82.7K | Sell |
410
-97
| -19% | -$19.6K | ﹤0.01% | 632 |
|
2022
Q4 | $110K | Hold |
507
| – | – | ﹤0.01% | 564 |
|
2022
Q3 | $100K | Buy |
+507
| New | +$100K | ﹤0.01% | 564 |
|
2022
Q2 | – | Sell |
-887
| Closed | -$252K | – | 449 |
|
2022
Q1 | $252K | Sell |
887
-765
| -46% | -$217K | 0.01% | 355 |
|
2021
Q4 | $622K | Buy |
1,652
+359
| +28% | +$135K | 0.02% | 296 |
|
2021
Q3 | $534K | Sell |
1,293
-188
| -13% | -$77.6K | 0.02% | 294 |
|
2021
Q2 | $603K | Buy |
+1,481
| New | +$603K | 0.02% | 297 |
|